Target intelligence / Profile preview

ERICH6 antisense RNA 1 (ERICH6-AS1)

Target
ERICH6-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ERICH6 antisense RNA 1 (ERICH6-AS1) is a long non-coding RNA transcribed from the antisense strand of the ERICH6 locus. As an antisense RNA, it regulates gene expression at various levels, including transcription and RNA stability, and may exert cis or trans regulatory effects. ERICH6-AS1 is involved in modulating cell proliferation, apoptosis, and immune responses. It has recently emerged as an immune-related lncRNA contributing to molecular signatures for prognostic prediction in cervical squamous cell carcinoma but has not yet been reported as a druggable or classic therapeutic target. Current research focuses on its utility as a biomarker and its mechanistic role in cancer and immune regulation, but there is no clinical use or direct pharmacological targeting established to date[5][6][7].

Other names
ERICH6-AS1
02

Biological functions

Cell proliferationApoptosisImmune responseGene expression regulation (through antisense mechanisms typical of lncRNAs, e.g., modulating methylation or RNA stability)
03

Disease associations

Cancer (especially as a prognostic marker in cervical squamous cell carcinoma; no direct therapeutic targeting reported yet)Potential roles in immune system-related diseases (due to immune modulatory functions; not yet clinically proven)
04

Biomarkers

Prognostic marker for cervical squamous cell carcinoma (based on immune-related lncRNA signatures for outcome prediction)Potential diagnostic marker role remains under research

Beyond the preview

Go deeper on ERICH6 antisense RNA 1 (ERICH6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ERICH6 antisense RNA 1 (ERICH6-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call